The rising prevalence in GLP-1 medications for metabolic conditions has sparked a debate about delivery routes : skin-applied devices versus tablets . Typically, GLP-1 drugs were solely available in https://phoenixelyb307052.blog-ezine.com/41482051/glp-1-transdermal-delivery-systems-vs-oral-medications-what-right-for-individuals